{"id":31867,"date":"2026-02-03T03:24:00","date_gmt":"2026-02-03T03:24:00","guid":{"rendered":"https:\/\/www.euegeajans.com\/?p=31867"},"modified":"2026-02-03T07:25:27","modified_gmt":"2026-02-03T07:25:27","slug":"doc-dr-sert-kanserle-mucadelede-basari-farkindalikla-mumkundur","status":"publish","type":"post","link":"https:\/\/www.euegeajans.com\/index.php\/2026\/02\/03\/doc-dr-sert-kanserle-mucadelede-basari-farkindalikla-mumkundur\/","title":{"rendered":"Do\u00e7. Dr. Sert,\u00a0\u201cKanserle m\u00fccadelede ba\u015far\u0131 fark\u0131ndal\u0131kla m\u00fcmk\u00fcnd\u00fcr\u201d"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>4 \u015eubat D\u00fcnya Kanser G\u00fcn\u00fc<\/strong><\/p>\n<p style=\"text-align: justify;\">Uluslararas\u0131 Kanserle M\u00fccadele \u00d6rg\u00fct\u00fc (UICC) \u00f6nc\u00fcl\u00fc\u011f\u00fcnde t\u00fcm d\u00fcnyada 4 \u015eubat, \u201cD\u00fcnya Kanser G\u00fcn\u00fc\u201d olarak idrak ediliyor. Bu kapsamda Ege \u00dcniversitesi (E\u00dc) Kanserle Sava\u015f Uygulama ve Ara\u015ft\u0131rma Merkezi M\u00fcd\u00fcr\u00fc Do\u00e7. Dr. Fatma Sert, kanserle m\u00fccadelede g\u00fcncel bilimsel geli\u015fmeler ve merkez b\u00fcnyesinde y\u00fcr\u00fct\u00fclen \u00e7al\u0131\u015fmalar hakk\u0131nda de\u011ferlendirmelerde bulundu.<\/p>\n<p style=\"text-align: justify;\">4 \u015eubat D\u00fcnya Kanser G\u00fcn\u00fc\u2019n\u00fcn bilimsel geli\u015fmeleri toplumla payla\u015fmak a\u00e7\u0131s\u0131ndan \u00f6nemli bir f\u0131rsat oldu\u011funu belirten Do\u00e7. Dr. Fatma Sert, kanserin d\u00fcnya genelinde ve \u00fclkemizde \u00f6nemli bir halk sa\u011fl\u0131\u011f\u0131 sorunu olmaya devam etti\u011fini ifade etti. \u00a0Do\u00e7. Dr. Sert, \u201cG\u00fcn\u00fcm\u00fczde kanser tedavisinde en \u00f6nemli geli\u015fmelerden biri, ki\u015fiselle\u015ftirilmi\u015f tedavi yakla\u015f\u0131mlar\u0131n\u0131n klinik uygulamaya girmi\u015f olmas\u0131d\u0131r. Molek\u00fcler biyoloji ve genetik alan\u0131ndaki ilerlemeler sayesinde, hastalar\u0131m\u0131z\u0131n t\u00fcm\u00f6r yap\u0131s\u0131na \u00f6zg\u00fc hedefli tedaviler uygulayabiliyoruz. Bu yakla\u015f\u0131mlar, tedavinin etkinli\u011fini art\u0131r\u0131rken yan etkilerin azalt\u0131lmas\u0131na da \u00f6nemli katk\u0131 sa\u011flamaktad\u0131r. Bununla birlikte imm\u00fcnoterapi alan\u0131ndaki geli\u015fmeler de kanser tedavisinde yeni bir d\u00f6nemi beraberinde getirmi\u015ftir. Ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin kanser h\u00fccrelerini tan\u0131y\u0131p yok etmesini hedefleyen bu tedaviler, \u00f6zellikle akci\u011fer kanseri, melanom ve baz\u0131 genito\u00fcriner kanser t\u00fcrlerinde sa\u011fkal\u0131m s\u00fcrelerini anlaml\u0131 \u015fekilde uzatm\u0131\u015ft\u0131r. Klasik kemoterapiden farkl\u0131 etki mekanizmalar\u0131yla \u00e7al\u0131\u015fan imm\u00fcnoterapiler, kanserle m\u00fccadelede umut verici sonu\u00e7lar ortaya koymaktad\u0131r\u201d \u00a0dedi.<\/p>\n<p style=\"text-align: justify;\"><b>\u201cErken tan\u0131, tedavi ba\u015far\u0131s\u0131n\u0131 belirleyen en kritik fakt\u00f6rd\u00fcr\u201d<\/b><\/p>\n<p style=\"text-align: justify;\">Erken tan\u0131 ve geli\u015fmi\u015f radyoterapinin tedavi ba\u015far\u0131s\u0131n\u0131 art\u0131rd\u0131\u011f\u0131n\u0131 belirten Do\u00e7. Dr. Sert, \u201cRadyoterapi teknolojilerindeki geli\u015fmeler de kanser tedavisinde \u00f6nemli kazan\u0131mlar sa\u011flamaktad\u0131r. Yo\u011funluk ayarl\u0131, g\u00f6r\u00fcnt\u00fc k\u0131lavuzlu ve stereotaktik radyoterapi teknikleri sayesinde t\u00fcm\u00f6rler \u00e7ok daha y\u00fcksek do\u011frulukla hedeflenebilmekte, sa\u011fl\u0131kl\u0131 dokular ise maksimum d\u00fczeyde korunabilmektedir. Bu sayede tedavi ba\u015far\u0131s\u0131 artarken, hastalar\u0131m\u0131z\u0131n ya\u015fam kalitesi de \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015fmektedir. Bunun yan\u0131 s\u0131ra erken tan\u0131 ve tarama programlar\u0131n\u0131n \u00f6nemi her ge\u00e7en g\u00fcn daha net bir \u015fekilde ortaya \u00e7\u0131kmaktad\u0131r. Meme, rahim a\u011fz\u0131, kolorektal ve prostat kanserleri ba\u015fta olmak \u00fczere pek \u00e7ok kanser t\u00fcr\u00fcnde hastal\u0131\u011f\u0131n erken evrede saptanmas\u0131, tedavi s\u00fcrecinin ba\u015far\u0131s\u0131n\u0131 do\u011frudan belirleyen en kritik fakt\u00f6rlerden biridir\u201d diye konu\u015ftu.<\/p>\n<p style=\"text-align: justify;\"><b>\u201cKanserle m\u00fccadelede aktif bir rol \u00fcstleniyoruz\u201d<\/b><\/p>\n<p style=\"text-align: justify;\">Kanserle m\u00fccadelede ba\u015far\u0131n\u0131n yaln\u0131zca t\u0131bbi geli\u015fmelere dayanmad\u0131\u011f\u0131n\u0131 vurgulayan Do\u00e7. Dr. Sert, \u201cMerkezi olarak bilimsel ara\u015ft\u0131rmalar, multidisipliner hasta yakla\u015f\u0131m\u0131, toplum bilgilendirme \u00e7al\u0131\u015fmalar\u0131 ve e\u011fitim faaliyetleriyle kanserle m\u00fccadelede aktif bir rol \u00fcstleniyoruz. Merkezimizde y\u00fcr\u00fct\u00fclen kanser kay\u0131tlar\u0131, \u00fclkemizin en k\u00f6kl\u00fc ve g\u00fcvenilir kanser veri kaynaklar\u0131 aras\u0131nda yer almaktad\u0131r. Ayn\u0131 zamanda y\u00fcr\u00fctt\u00fc\u011f\u00fcm\u00fcz sosyal sorumluluk projeleri ve klinik \u00e7al\u0131\u015fmalarla \u00e7a\u011fda\u015f tedavi yakla\u015f\u0131mlar\u0131n\u0131n geli\u015ftirilmesine katk\u0131 sa\u011fl\u0131yor, hastalar\u0131m\u0131za en g\u00fcncel bilimsel veriler \u0131\u015f\u0131\u011f\u0131nda hizmet sunuyoruz. Bu anlaml\u0131 g\u00fcnde bir kez daha vurgulamak isteriz ki, kanserle m\u00fccadelede ba\u015far\u0131 yaln\u0131zca bilimsel geli\u015fmelerle de\u011fil; toplumsal fark\u0131ndal\u0131k, sa\u011fl\u0131kl\u0131 ya\u015fam al\u0131\u015fkanl\u0131klar\u0131 ve d\u00fczenli sa\u011fl\u0131k kontrolleriyle m\u00fcmk\u00fcnd\u00fcr. 4 \u015eubat D\u00fcnya Kanser G\u00fcn\u00fc\u2019n\u00fcn toplumsal bilin\u00e7lenmeyi art\u0131rmas\u0131n\u0131 ve kanserle m\u00fccadelede umutlar\u0131m\u0131z\u0131 g\u00fc\u00e7lendirmesini temenni ediyoruz\u201d dedi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 \u015eubat D\u00fcnya Kanser G\u00fcn\u00fc Uluslararas\u0131 Kanserle M\u00fccadele \u00d6rg\u00fct\u00fc (UICC) \u00f6nc\u00fcl\u00fc\u011f\u00fcnde t\u00fcm d\u00fcnyada 4 \u015eubat,&#8230;<\/p>\n","protected":false},"author":2,"featured_media":31868,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,99,1,70],"tags":[],"class_list":["post-31867","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bilim","category-egitim","category-gncl","category-kampus"],"featured_image_urls":{"full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",900,600,false],"thumbnail":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",150,100,false],"medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",300,200,false],"medium_large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",640,427,false],"large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",640,427,false],"1536x1536":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",900,600,false],"2048x2048":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",900,600,false],"newsphere-slider-full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",900,600,false],"newsphere-featured":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",900,600,false],"newsphere-medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2026\/02\/Doc.-Dr.-Fatma-Sert-.jpeg",570,380,false]},"author_info":{"display_name":"Editor","author_link":"https:\/\/www.euegeajans.com\/index.php\/author\/editor\/"},"category_info":"<a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/bilim\/\" rel=\"category tag\">Bilim<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/egitim\/\" rel=\"category tag\">E\u011fitim<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/gncl\/\" rel=\"category tag\">G\u00fcncel<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/kampus\/\" rel=\"category tag\">Kamp\u00fcs<\/a>","tag_info":"Kamp\u00fcs","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/31867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/comments?post=31867"}],"version-history":[{"count":1,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/31867\/revisions"}],"predecessor-version":[{"id":31869,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/31867\/revisions\/31869"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media\/31868"}],"wp:attachment":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media?parent=31867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/categories?post=31867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/tags?post=31867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}